Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: December 8, 2021

DrugPatentWatch Database Preview

Patent: 10,160,747

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 10,160,747
Title:Compounds and methods for kinase modulation, and indications therefor
Abstract: Disclosed are compounds of Formula I(b): ##STR00001## or a pharmaceutically acceptable salt, a solvate, a tautomer, an isomer or a deuterated analog thereof, wherein Ring A, Ring HD, J, each T, R.sup.3, R.sup.4, R.sup.5, each R.sup.7, and m are as described in any of the embodiments described in this disclosure; compositions thereof; and uses thereof.
Inventor(s): Lin; Jack (Hercules, CA), Ibrahim; Prabha N. (Mountain View, CA), Albers; Aaron (San Francisco, CA), Buell; John (San Francisco, CA), Guo; Zuojun (Pasadena, CA), Pham; Phuongly (San Francisco, CA), Powers; Hannah (San Francisco, CA), Shi; Songyuan (Fremont, CA), Spevak; Wayne (Berkeley, CA), Wu; Guoxian (Foster City, CA), Zhang; Jiazhong (Foster City, CA), Zhang; Ying (Fremont, CA), Wu; Jeffrey (Berkeley, CA)
Assignee: Plexxikon Inc. (Berkeley, CA)
Application Number:15/460,095
Patent Claims:see list of patent claims

Details for Patent 10,160,747

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Recordati Rare Diseases, Inc. ELSPAR asparaginase For Injection 101063 1978-01-10 ⤷  Free Forever Trial 2036-03-16
Genentech, Inc. RITUXAN rituximab Injection 103705 1997-11-26 ⤷  Free Forever Trial 2036-03-16
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 1998-09-25 ⤷  Free Forever Trial 2036-03-16
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 2017-02-10 ⤷  Free Forever Trial 2036-03-16
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.